Injured kidney cells express SM22α (transgelin): Unique features distinct from α-smooth muscle actin (αSMA)

Nephrology

Volumn 16, Issue 2, 2011, Pages 211-218

  Sakamaki, Yuichi ^a   Sakatsume, Minoru ^a   Wang, Xingzhi ^a   Inomata, Shigeru ^a   Yamamoto, Tadashi ^a   Gejyo, Fumitake ^a   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

smooth muscle actin; glomerulonephritis; injury marker; SM22 ; transgelin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; TRANSGELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWMAN CAPSULE; EPITHELIUM; HISTOLOGY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY INTERSTITIUM; MALE; MESANGIUM CELL; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACTINS; ANIMALS; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GLOMERULONEPHRITIS; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; MALE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; PODOCYTES; RATS; RATS, INBRED WKY;

EID: 79551515861     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01322.x     Document Type: Article

References (34)

1. Lees-Miller JP, Heeley DH, Smillie LB,. An abundant and novel protein of 22 kda (SM22) is widely distributed in smooth muscles. Purification from bovine aorta. Biochem. J. 1987; 244: 705-9.
2. Shapland C, Hsuan JJ, Totty NF, Lawson D,. Purification and properties of transgelin: A transformation and shape change sensitive actin-gelling protein. J. Cell Biol. 1993; 121: 1065-73.
3. Almendral JM, Santaren JF, Perera J, Zerial M, Bravo R,. Expression, cloning and cDNA sequence of a fibroblast serum-regulated gene encoding a putative actin-associated protein (p27). Exp. Cell Res. 1989; 181: 518-30.
4. Duband JL, Gimona M, Scatena M, Sartore S, Small JV,. Calponin and SM22 as differentiation markers of smooth muscle: Spatiotemporal distribution during avian embryonic development. Differentiation 1993; 55: 1-11.
5. Pearlstone JR, Weber M, Lees-Miller JP, Carpenter MR, Smillie LB,. Amino acid sequence of chicken gizzard smooth muscle SM22 alpha. J. Biol. Chem. 1987; 262: 5985-91.
6. Lawson D, Harrison M, Shapland C,. Fibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil. Cytoskeleton. 1997; 38: 250-7.
7. Assinder SJ, Stanton JA, Prasad PD,. Transgelin: An actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. 2009; 41: 482-6.
8. Fu Y, Liu HW, Forsythe SM, et al. Mutagenesis analysis of human SM22: Characterization of actin binding. J. Appl. Physiol. 2000; 89: 1985-90.
9. Zhang JC, Kim S, Helmke BP, et al. Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol. Cell Biol. 2001; 21: 1336-44.
10. Feil S, Hofmann F, Feil R,. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ. Res. 2004; 94: 863-5. Epub 2004 March 2025.
11. Shields JM, Rogers-Graham K, Der CJ,. Loss of transgelin in breast and colon tumors and in RIE-1 cells by ras deregulation of gene expression through Raf-independent pathways. J. Biol. Chem. 2002; 277: 9790-9.
12. Wulfkuhle JD, Sgroi DC, Krutzsch H, et al. F, 3rd, Zhao Y, Steeg PS: Proteomics of human breast ductal carcinoma in situ. Cancer Res. 2002; 62: 6740-9.
13. Yu H, Konigshoff M, Jayachandran A, et al. Transgelin is a direct target of TGF-beta/smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 2008; 22: 1778-89.
14. Nair RR, Solway J, Boyd DD,. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kda type iv collagenase (mmp-9) expression. J. Biol. Chem. 2006; 281: 26424-36.
15. Zhao L, Wang H, Deng YJ, et al. Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod. Pathol. 2009; 22: 786-96.
16. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA,. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002; 3: 349-63.
17. Gabbiani G,. The biology of the myofibroblast. Kidney Int. 1992; 41: 530-2.
18. Bariety J, Bruneval P, Hill GS, Mandet C, Jacquot C, Meyrier A,. Transdifferentiation of epithelial glomerular cells. J. Am. Soc. Nephrol. 2003; 14 (Suppl 1): S42-47.
19. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J. Clin. Invest. 1991; 87: 847-58.
20. Goumenos DS, Brown CB, Shortland J, el Nahas AM,. Myofibroblasts, predictors of progression of mesangial iga nephropathy? Nephrol. Dial. Transplant. 1994; 9: 1418-25.
21. Zhang G, Moorhead PJ, el Nahas AM,. Myofibroblasts and the progression of experimental glomerulonephritis. Exp. Nephrol. 1995; 3: 308-18.
22. Ogawa A, Sakatsume M, Wang X, et al. Sm22alpha: The novel phenotype marker of injured glomerular epithelial cells in anti-glomerular basement membrane nephritis. Nephron. Exp. Nephrol. 2007; 106: e77-87.
23. Saga D, Sakatsume M, Ogawa A, et al. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis. Kidney Int. 2005; 67: 1821-9.
24. Tsubata Y, Sakatsume M, Ogawa A, et al. Expression of allograft inflammatory factor-1 in kidneys: A novel molecular component of podocyte. Kidney Int. 2006; 70: 1948-54.
25. Kuroda T, Kawasaki K, Oite T, Arakawa M, Shimizu F,. Nephrotoxic serum nephritis in nude rats: The role of cell-mediated immunity. Nephron 1994; 68: 360-5.
26. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F,. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 2001; 60: 1645-57.
27. Sakatsume M, Kadomura M, Sakata I, et al. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. Kidney Int. 2001; 59: 1911-8.
28. Kamiie J, Nameta M, Ma M, et al. Localization and expression of the aquaporin-1 water channel in mesangial cells in the human glomerulus. Arch. Histol. Cytol. 2002; 65: 83-90.
29. Goumenos D, Tsomi K, Iatrou C, et al. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol. Dial. Transplant. 1998; 13: 1652-61.
30. Utsunomiya Y, Kawamura T, Abe A, et al. Significance of mesangial expression of alpha-smooth muscle actin in the progression of IgA nephropathy. Am. J. Kidney Dis. 1999; 34: 902-10.
31. Ng YY, Fan JM, Mu W, et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol. Dial. Transplant. 1999; 14: 2860-72.
32. Fujigaki Y, Sun DF, Fujimoto T, et al. Mechanisms and kinetics of bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents. Nephron 2002; 92: 203-12.
33. Shirato I, Sakai T, Kimura K, Tomino Y, Kriz W,. Cytoskeletal changes in podocytes associated with foot process effacement in masugi nephritis. Am. J. Pathol. 1996; 148: 1283-96.
34. Kaneko Y, Sakatsume M, Xie Y, et al. Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis. J. Immunol. 2003; 170: 3377-85.